Skip to main content
. 2021 Aug 24;198(2):123–134. doi: 10.1007/s00066-021-01833-x

Table 2.

Indications for concomitant chemotherapy in the treatment of salivary gland cancer

Indication for chemotherapy Definitive treatment situation Postoperative treatment situation
For all high-risk salivary gland cancers according to recommendations for squamous cell carcinomas of the head and neck region 15 (27%) 10 (24%)
For all kinds of salivary gland cancers according to recommendations for squamous cell carcinomas of the head and neck region 9 (16%) 4 (10%)
According to individual decision 31 (56%) 28 (67%)